Ghrelin O-acyltransferase inhibitors

This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (

Saved in:
Bibliographic Details
Main Authors EIDAM, Hilary Schenck, JOSHI, Hemant, SU, Dai-Shi, BANDYOPADHYAY, Anish, CHEUNG, Mui
Format Patent
LanguageEnglish
Published 13.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (
AbstractList This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of metabolic disorders (
Author SU, Dai-Shi
JOSHI, Hemant
BANDYOPADHYAY, Anish
EIDAM, Hilary Schenck
CHEUNG, Mui
Author_xml – fullname: EIDAM, Hilary Schenck
– fullname: JOSHI, Hemant
– fullname: SU, Dai-Shi
– fullname: BANDYOPADHYAY, Anish
– fullname: CHEUNG, Mui
BookMark eNrjYmDJy89L5WRQcc8oSs3JzFPw101MrswpKUrMK05LLUosTlXIzMvITMosyS8q5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8Y6hRgaGlkaGxibmFo6GxsSpAgCrOymq
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID AU2019213478A1
GroupedDBID EVB
ID FETCH-epo_espacenet_AU2019213478A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:44:52 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU2019213478A13
Notes Application Number: AU20190213478
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200813&DB=EPODOC&CC=AU&NR=2019213478A1
ParticipantIDs epo_espacenet_AU2019213478A1
PublicationCentury 2000
PublicationDate 20200813
PublicationDateYYYYMMDD 2020-08-13
PublicationDate_xml – month: 08
  year: 2020
  text: 20200813
  day: 13
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
RelatedCompanies_xml – name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Score 3.280438
Snippet This invention relates to novel compounds according to Formula (I) which are inhibitors of ghrelin O-acyltransferase (GOAT), to pharmaceutical compositions...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Ghrelin O-acyltransferase inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200813&DB=EPODOC&locale=&CC=AU&NR=2019213478A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQATYxklOSTYx1LZKBKdjEODVNNynF0kTXMBnYlAOdGG6cCJrR9fUz8wg18YowjWBiyIHthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5q0N4xaDLf0FjNxcnWNcDfxd9ZzdkZ2JNU8wsCDQVagg4vM7dwBPaVWIENaXNQfnANcwLtSylArlTcBBnYAoDm5ZUIMTCl5gkzcDrD7l4TZuDwhU55A5nQ3FcswqDiDgx4YLNQwV83MbkypwTc5kwtAtZDCpl5GZlJmaCbc0QZlN1cQ5w9dIHWxcN9F-8Yiuw2YzEGFmC_P1WCQcHQKDUZ2CFKTEsxTjOxNLRMSks0TTY3SEoySLQwNTC2lGSQwWeSFH5paQYuUHiBhkcNjWUYWEqKSlNlgfVrSZIcOFgAEx99TQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL8s0zjfdGqcTiVx4Y0IFgQeFrPxIeqAxTCzN0ILRJIFlw1j_O-9EqZ72lvTJv249Hq_3117BRggxGApU4lkMNzBKslyiaamKikMoRzPGE4SHtH1gwdvpr7MtXkLFpu3MHWe0O86OSJqFEN9r-rzevnvxLLru5XrO1pg1eejGw1tsWHHPJivENEeD51paIeWaFnIJMXgjbsCTZ68TDdGyJX2EGTrXB-c9zF_l7LcNiruEexPsb-yOoZWVnahY23-XuvCgd-EvLHYaN_6BAZPKHiEhUIoJexnUdWYM1uhHRKK8qOgBf855xRuXSeyPAmHi_9WF49m23MjZ9BG3p-dg6DcZwwJUZKnJFdNxaR5ojFdplRODE0mZg_6u3q62N18Ax0v8ifx5Dl4vYRDLjvuKlVIH9rV6iu7Qltb0etaRL8ecoBA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Ghrelin+O-acyltransferase+inhibitors&rft.inventor=EIDAM%2C+Hilary+Schenck&rft.inventor=JOSHI%2C+Hemant&rft.inventor=SU%2C+Dai-Shi&rft.inventor=BANDYOPADHYAY%2C+Anish&rft.inventor=CHEUNG%2C+Mui&rft.date=2020-08-13&rft.externalDBID=A1&rft.externalDocID=AU2019213478A1